Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
Source: Pixabay

Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Midatech Pharma just received verbal confirmation from Polish regulators to conduct the first European in-human study for a treatment that could potential aid those with carcinoid cancer and acromegaly, reported…

Continue Reading Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Editor’s Choice: Thanksgiving Gratitude in the Face of Rare Disease

Happy Thanksgiving Patient Worthians! We hope you are recovering from big meals and continuing to spend time with family this weekend. Editor's choice this week focuses on gratitude expressed by our…

Continue Reading Editor’s Choice: Thanksgiving Gratitude in the Face of Rare Disease